Press Releases

November 14, 2019

VIVO Cannabis™ Reports Third Quarter 2019 Results

Net revenue was $6.3 million in the quarter, a 19% increase, quarter-over-quarter, and 175% increase over Q3 2018, and $16.6 million year-to-date, a 328% increase over the same period last year….

Read More

November 12, 2019

VIVO Cannabis Receives Conditional Approval to Graduate to the Toronto Stock Exchange

VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”) is pleased to announce that it has received conditional approval from the Toronto Stock Exchange (the “TSX”) to graduate…

Read More

November 1, 2019

VIVO Cannabis to Host Third Quarter 2019 Financial Results Conference Call

VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”) today announced that senior management will host a conference call to discuss the Company’s third quarter 2019 results. The…

Read More

October 29, 2019

VIVO and CB2 Insights Enter Technology and Research Partnership

Partnership to focus on implementing a medical product development strategy for VIVO’s global medical cannabis offering, utilizing CB2 Insights’ leading technology platform Sail and research…

Read More

October 3, 2019

VIVO Cannabis™ Reaffirms Timing of First Harvest at Kimmetts and Additional 2020 Cultivation Plans

Announcements made during VIVO’s Analyst and Investor Day Held at Napanee Operations NAPANEE, ON, Oct. 3, 2019 /CNW/ – VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”)…

Read More

September 17, 2019

VIVO Cannabis™ Partners with Linneo Health to Supply Medical Cannabis in Europe

VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”) today announced it has partnered with Linneo Health S.L. (“Linneo Health”), a subsidiary of Alcaliber S.A., to be its…

Read More

August 28, 2019

VIVO Cannabis™ Reports Q2 2019 Financial and Operating Results

Net revenue was $5.3 million in the quarter, a five-fold increase over the same quarter last year. Cultivation license was granted in the third quarter of 2019 for four new seasonal greenhouses in…

Read More

August 15, 2019

VIVO Cannabis to Host Second Quarter 2019 Financial Results Conference Call

VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”) today announced that senior management will host a conference call to discuss the Company’s second quarter 2019 results….

Read More

August 6, 2019

VIVO Announces 50% Increase in Licensed Capacity and Third Licensed Site with New Innovative Seasonal Greenhouses

VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”) today announced that the Company’s wholly-owned subsidiary, ABcann Medicinals Inc., has been granted a Standard Cultivation…

Read More

July 30, 2019

VIVO Commences Extraction Operations in Napanee, Ontario

VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”) today announced that the Company’s wholly-owned subsidiary, ABcann Medicinals Inc., has received approval from Health…

Read More

VIVO is a family of premium brands and businesses, building a world-class cannabis company through the acquisition and development of specialty brands.